Plexus Corp. (NASDAQ:PLXS) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Plexus Corp. (NASDAQ:PLXSGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the four research firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $107.75.

PLXS has been the subject of a number of recent research reports. Needham & Company LLC increased their target price on Plexus from $107.00 to $114.00 and gave the company a “buy” rating in a research note on Friday, April 26th. Stifel Nicolaus increased their target price on Plexus from $90.00 to $95.00 and gave the company a “hold” rating in a research note on Friday, April 26th. Benchmark reiterated a “buy” rating and issued a $110.00 target price on shares of Plexus in a research note on Wednesday, January 17th. TheStreet lowered Plexus from a “b” rating to a “c+” rating in a research note on Tuesday, February 13th. Finally, Sidoti lowered Plexus from a “buy” rating to a “neutral” rating and set a $112.00 target price for the company. in a research note on Tuesday, January 9th.

View Our Latest Stock Analysis on Plexus

Plexus Stock Performance

Plexus stock opened at $101.01 on Friday. The stock’s 50-day moving average is $94.76 and its 200-day moving average is $98.56. The company has a market cap of $2.79 billion, a price-to-earnings ratio of 27.90 and a beta of 1.02. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.51 and a quick ratio of 0.64. Plexus has a 12 month low of $83.84 and a 12 month high of $114.06.

Plexus (NASDAQ:PLXSGet Free Report) last released its quarterly earnings data on Wednesday, April 24th. The technology company reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.07. Plexus had a return on equity of 10.77% and a net margin of 2.54%. The company had revenue of $966.90 million for the quarter, compared to the consensus estimate of $950.75 million. During the same period last year, the business posted $1.45 EPS. The company’s quarterly revenue was down 9.7% compared to the same quarter last year. Equities analysts anticipate that Plexus will post 4.36 earnings per share for the current year.

Insider Transactions at Plexus

In other news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $94.00, for a total value of $188,000.00. Following the completion of the transaction, the chief executive officer now owns 121,310 shares in the company, valued at approximately $11,403,140. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, insider Steven J. Frisch sold 3,567 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $97.10, for a total value of $346,355.70. Following the sale, the insider now owns 65,212 shares of the company’s stock, valued at approximately $6,332,085.20. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $94.00, for a total value of $188,000.00. Following the completion of the sale, the chief executive officer now directly owns 121,310 shares in the company, valued at approximately $11,403,140. The disclosure for this sale can be found here. In the last quarter, insiders sold 24,631 shares of company stock worth $2,373,533. 2.39% of the stock is currently owned by corporate insiders.

Institutional Trading of Plexus

Hedge funds have recently made changes to their positions in the stock. Qube Research & Technologies Ltd raised its stake in Plexus by 93.7% during the 3rd quarter. Qube Research & Technologies Ltd now owns 22,691 shares of the technology company’s stock valued at $2,110,000 after acquiring an additional 10,975 shares in the last quarter. Avior Wealth Management LLC raised its stake in Plexus by 115.2% during the 4th quarter. Avior Wealth Management LLC now owns 2,118 shares of the technology company’s stock valued at $229,000 after acquiring an additional 1,134 shares in the last quarter. Vanguard Group Inc. raised its stake in Plexus by 1.4% during the 3rd quarter. Vanguard Group Inc. now owns 3,453,940 shares of the technology company’s stock valued at $321,147,000 after acquiring an additional 47,762 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Plexus during the 3rd quarter valued at $715,000. Finally, First Eagle Investment Management LLC bought a new stake in Plexus during the 3rd quarter valued at $5,865,000. Institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.